SCHEMBL7082997

SCHEMBL7082997

COc1ccc(C(O)(C(=O)OCC(=CO)c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
ALDH1A1 P00352 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
PTGS2 P35354 1/20 0.40
BCHE P06276 1/20 0.40
CYP3A4 P08684 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
CHRM2 P08172 2/20 0.40
CHRM1 P11229 2/20 0.40
CHRM3 P20309 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromomethane SCHEMBL14142659 0.98 CES2 (0.41) CES2CES1NPC1RAB9AALDH1A1
SCHEMBL7085430 0.87 NPC1 (0.43) CES2CES1NPC1RAB9AALDH1A1
Bromomethane SCHEMBL7086772 0.85 NPC1 (0.41) CES2CES1NPC1RAB9AALDH1A1
SCHEMBL931372 0.85 CHRM2 (0.39) NPC1RAB9AALDH1A1KCNK9SMN1; SMN2
SCHEMBL14142347 0.85 PDPK1 (0.46) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL7082002 0.85 HPGD (0.43) NPC1RAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL7085988 0.85 MEN1 (0.43) CES2CES1NPC1RAB9AALDH1A1
SCHEMBL14142733 0.84 POLB (0.40) NPC1RAB9AALDH1A1HTTSMN1; SMN2
Bromomethane SCHEMBL7081929 0.84 KMT2A (0.44) CES2CES1ALDH1A1NPSR1MEN1
Bromomethane SCHEMBL118164 0.84 CHRM2 (0.39) NPC1RAB9AALDH1A1KCNK9SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1328524-B1 NOVEL ANTICHOLINERGICS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2012-12-12 EP disclosed
EP-1328524-A2 NOVEL ANTICHOLINERGICS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2003-07-23 EP disclosed
WO-2002032898-A2 NOVEL ANTICHOLINERGICS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2002-04-25 WO disclosed